David Clayton, MD, MBA

Chief Strategy Officer (CSO) at MicroHealth

David Clayton, MD, MBA, has an extensive work experience spanning various industries. David currently holds the position of Chief Strategy Officer (CSO) at MicroHealth, where they are responsible for designing and implementing business processes to enhance stakeholder value. As the Chief Medical Officer at MicroHealth, Dr. Clayton leads multiple healthcare technology programs, including a significant deployment of electronic health records for the Department of State.

Prior to their current roles, Dr. Clayton worked as a Senior Consultant at the San Diego County Public Health Department, where they provided expert guidance and advice. David also served as the National Medical Director at GAPS Health, overseeing a nationwide network of physicians to deliver quality care to patients in skilled nursing facilities. Additionally, they played a crucial role in implementing telehealth services in rural areas and coordinating the public health response to the COVID-19 pandemic.

Dr. Clayton also has experience as the CEO and Founder of rxfive.com, a technology company focused on improving chronic disease management and reducing costs. David successfully developed a patient-centric platform that combines education and communication to drive positive behavioral changes and enhance care quality.

Furthermore, Dr. Clayton worked as a Physician at Scripps Health, where they provided primary care services, taught in residency programs, and served as a physician advisor for managed care plans. David also held a leadership position at UBS Investment Bank as the Director of Healthcare Investment Banking. In this role, they led global teams in evaluating and executing strategic options for healthcare companies, conducted due diligence, and marketed transactions to internal teams and investors. Additionally, Dr. Clayton gained experience as an Equity Research Analyst in the biotechnology sector at Goldman Sachs.

Overall, Dr. David Clayton's work experience showcases their extensive expertise in healthcare, business strategy, technology, and finance.

David Clayton, MD, MBA completed their Bachelor of Science degree in Chemical Biology at Stevens Institute of Technology from 1991 to 1994. David then pursued their medical education at the University of Medicine and Dentistry of New Jersey - New Jersey Medical School, where they earned their MD degree in Internal Medicine from 1994 to 1998. Later, they attended Columbia Business School from 2001 to 2003 and obtained an MBA degree with a focus on Finance and Management.

Links

Previous companies

Goldman Sachs logo
UBS logo

Timeline

  • Chief Strategy Officer (CSO)

    April 1, 2023 - present

  • Chief Medical Officer

    March, 2022